Xcytrin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The FDA largely approves or disapproves drugs based on average treatment effects. Given widespread heterogeneity in treatment…
Despite recent advances in technology, targeting, and chemotherapy, brain metastasis from non-small cell lung cancer (NSCLC…
Liquid chromatography–fluorescence (LC–FLS), liquid chromatography–tandem mass spectrometry (LC–MS/MS) and inductively coupled…
The biotransformation of motexafin gadolinium (MGd, Xcytrin) was investigated in subcellular rat and human liver fractions…
The FDA has made great strides over the past twenty years in loosening drug approval regulations to speed important, life-saving…
Motexafin gadolinium (MGd, Xcytrin) is a tumor-selective redox mediator that oxidizes intracellular reducing metabolites and…
3203 Background: Motexafin gadolinium (Xcytrin) is a novel therapeutic that concentrates in tumors and generates reactive oxygen…
2016 Motexafin gadolinium (MGd, Xcytrin ® ) is a redox mediator that catalyzes the oxidation of intracellular reducing…